258 related articles for article (PubMed ID: 22547818)
1. Cutaneous β-human papillomavirus E6 proteins bind Mastermind-like coactivators and repress Notch signaling.
Tan MJ; White EA; Sowa ME; Harper JW; Aster JC; Howley PM
Proc Natl Acad Sci U S A; 2012 Jun; 109(23):E1473-80. PubMed ID: 22547818
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous papillomavirus E6 oncoproteins associate with MAML1 to repress transactivation and NOTCH signaling.
Brimer N; Lyons C; Wallberg AE; Vande Pol SB
Oncogene; 2012 Oct; 31(43):4639-46. PubMed ID: 22249263
[TBL] [Abstract][Full Text] [Related]
3. Association of papillomavirus E6 proteins with either MAML1 or E6AP clusters E6 proteins by structure, function, and evolutionary relatedness.
Brimer N; Drews CM; Vande Pol SB
PLoS Pathog; 2017 Dec; 13(12):e1006781. PubMed ID: 29281732
[TBL] [Abstract][Full Text] [Related]
4. Genus beta human papillomavirus E6 proteins vary in their effects on the transactivation of p53 target genes.
White EA; Walther J; Javanbakht H; Howley PM
J Virol; 2014 Aug; 88(15):8201-12. PubMed ID: 24850740
[TBL] [Abstract][Full Text] [Related]
5. The human papillomavirus type 8 E6 protein interferes with NOTCH activation during keratinocyte differentiation.
Meyers JM; Spangle JM; Munger K
J Virol; 2013 Apr; 87(8):4762-7. PubMed ID: 23365452
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous HPV8 and MmuPV1 E6 Proteins Target the NOTCH and TGF-β Tumor Suppressors to Inhibit Differentiation and Sustain Keratinocyte Proliferation.
Meyers JM; Uberoi A; Grace M; Lambert PF; Munger K
PLoS Pathog; 2017 Jan; 13(1):e1006171. PubMed ID: 28107544
[TBL] [Abstract][Full Text] [Related]
7. Cottontail rabbit papillomavirus E6 proteins: Interaction with MAML1 and modulation of the Notch signaling pathway.
Lim J; Frecot DI; Stubenrauch F; Iftner T; Simon C
Virology; 2022 Nov; 576():52-60. PubMed ID: 36155393
[TBL] [Abstract][Full Text] [Related]
8. Interactions between E6AP and E6 proteins from alpha and beta HPV types.
Thomas M; Tomaić V; Pim D; Myers MP; Tommasino M; Banks L
Virology; 2013 Jan; 435(2):357-62. PubMed ID: 23206439
[TBL] [Abstract][Full Text] [Related]
9. An enhanced triple fluorescence flow-cytometry-based assay shows differential activation of the Notch signaling pathway by human papillomavirus E6 proteins.
Lim J; Straub E; Stubenrauch F; Iftner T; Schindler M; Simon C
Sci Rep; 2022 Feb; 12(1):3000. PubMed ID: 35194094
[TBL] [Abstract][Full Text] [Related]
10. MAML1-induced HPV E6 oncoprotein stability is required for cellular proliferation and migration of cervical tumor-derived cells.
Skelin J; Đukić A; Filić V; Hufbauer M; Akgül B; Thomas M; Banks L; Tomaić V
J Med Virol; 2023 Mar; 95(3):e28624. PubMed ID: 36852660
[TBL] [Abstract][Full Text] [Related]
11. High-Risk Mucosal Human Papillomavirus 16 (HPV16) E6 Protein and Cutaneous HPV5 and HPV8 E6 Proteins Employ Distinct Strategies To Interfere with Interferon Regulatory Factor 3-Mediated Beta Interferon Expression.
Poirson J; Suarez IP; Straub ML; Cousido-Siah A; Peixoto P; Hervouet E; Foster A; Mitschler A; Mukobo N; Chebaro Y; Garcin D; Recberlik S; Gaiddon C; Altschuh D; Nominé Y; Podjarny A; Trave G; Masson M
J Virol; 2022 May; 96(10):e0187521. PubMed ID: 35475668
[TBL] [Abstract][Full Text] [Related]
12. Mastermind-like 1 (MamL1) and mastermind-like 3 (MamL3) are essential for Notch signaling in vivo.
Oyama T; Harigaya K; Sasaki N; Okamura Y; Kokubo H; Saga Y; Hozumi K; Suganami A; Tamura Y; Nagase T; Koga H; Nishimura M; Sakamoto R; Sato M; Yoshida N; Kitagawa M
Development; 2011 Dec; 138(23):5235-46. PubMed ID: 22069191
[TBL] [Abstract][Full Text] [Related]
13. HPV 5 and 8 E6 abrogate ATR activity resulting in increased persistence of UVB induced DNA damage.
Wallace NA; Robinson K; Howie HL; Galloway DA
PLoS Pathog; 2012; 8(7):e1002807. PubMed ID: 22807682
[TBL] [Abstract][Full Text] [Related]
14. E6 proteins from multiple human betapapillomavirus types degrade Bak and protect keratinocytes from apoptosis after UVB irradiation.
Underbrink MP; Howie HL; Bedard KM; Koop JI; Galloway DA
J Virol; 2008 Nov; 82(21):10408-17. PubMed ID: 18715924
[TBL] [Abstract][Full Text] [Related]
15. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
Goodwin EC; DiMaio D
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078
[TBL] [Abstract][Full Text] [Related]
16. Papillomavirus-associated squamous skin cancers following transplant immunosuppression: one Notch closer to control.
Connolly K; Manders P; Earls P; Epstein RJ
Cancer Treat Rev; 2014 Mar; 40(2):205-14. PubMed ID: 24051018
[TBL] [Abstract][Full Text] [Related]
17. Structure of High-Risk Papillomavirus 31 E6 Oncogenic Protein and Characterization of E6/E6AP/p53 Complex Formation.
Conrady MC; Suarez I; Gogl G; Frecot DI; Bonhoure A; Kostmann C; Cousido-Siah A; Mitschler A; Lim J; Masson M; Iftner T; Stubenrauch F; Travé G; Simon C
J Virol; 2020 Dec; 95(2):. PubMed ID: 33115863
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus type 16 E6 induces self-ubiquitination of the E6AP ubiquitin-protein ligase.
Kao WH; Beaudenon SL; Talis AL; Huibregtse JM; Howley PM
J Virol; 2000 Jul; 74(14):6408-17. PubMed ID: 10864652
[TBL] [Abstract][Full Text] [Related]
19. The E6AP ubiquitin ligase is required for transactivation of the hTERT promoter by the human papillomavirus E6 oncoprotein.
Liu X; Yuan H; Fu B; Disbrow GL; Apolinario T; Tomaic V; Kelley ML; Baker CC; Huibregtse J; Schlegel R
J Biol Chem; 2005 Mar; 280(11):10807-16. PubMed ID: 15655249
[TBL] [Abstract][Full Text] [Related]
20. The E6 oncoproteins from human betapapillomaviruses differentially activate telomerase through an E6AP-dependent mechanism and prolong the lifespan of primary keratinocytes.
Bedard KM; Underbrink MP; Howie HL; Galloway DA
J Virol; 2008 Apr; 82(8):3894-902. PubMed ID: 18256157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
